Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Hind Rafei, Elias Joseph Jabbour, Hagop Kantarjian, Kaylyn D. Sinicrope, Carlos Kamiya-Matsuoka, Rohtesh S. Mehta, Naval G. Daver, Tapan M. Kadia, Kiran Naqvi, Jorge Cortes, Marina Konopleva

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)3292-3295
Number of pages4
JournalLeukemia and Lymphoma
Volume60
Issue number13
DOIs
StatePublished - Nov 10 2019
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rafei, H., Jabbour, E. J., Kantarjian, H., Sinicrope, K. D., Kamiya-Matsuoka, C., Mehta, R. S., Daver, N. G., Kadia, T. M., Naqvi, K., Cortes, J., & Konopleva, M. (2019). Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series. Leukemia and Lymphoma, 60(13), 3292-3295. https://doi.org/10.1080/10428194.2019.1633635